Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in...

por Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galyavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Publicado 2021

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3...

por Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galiavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Publicado 2020